A novel variant in the 3' untranslated region of the CDK4 gene: Interference with microRNA target sites and role in increased risk of cutaneous melanoma

Cancer Genetics

Volumn 207, Issue 4, 2014, Pages 168-169

  Pedace, Lucia ^a   Cozzolino, Angela M ^a   Barboni, Luana ^a   De Bernardo, Carmelilia ^a   Grammatico, Paola ^a   De Simone, Paola ^b   Buccini, Pierluigi ^b   Ferrari, Angela ^b   Catricalà, Caterina ^b   Colombo, Teresa ^c   Donati, Pietro ^b   Morrone, Aldo ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c CNR   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MICRORNA 34A;

3' UNTRANSLATED REGION; ADULT; BINDING SITE; CANCER RISK; CANCER SUSCEPTIBILITY; CDK4 GENE; CDK6 GENE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MELANOMA; MICRORNA 34A GENE; MIDDLE AGED; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; BINDING SITES; CYCLIN-DEPENDENT KINASE 4; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MELANOMA; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SKIN NEOPLASMS;

EID: 84901612215     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2014.03.005     Document Type: Letter

References (18)

1. Skeeles L.E., Fleming J.L., Mahler K.L., et al. The impact of 3'UTR variants on differential expression of candidate cancer susceptibility genes. PLoS One 2013, 8:e58609.
2. Xiong F., Wu C., Chang J., et al. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 2011, 71:5175-5181.
3. Jacobs G., Hellmig S., Huse K., et al. Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma. Haematologica 2011, 96:987-995.
4. Wang C., Guo Z., Wu C., et al. Apolymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer. Cancer Genet 2012, 205:373-376.
5. Chin L.J., Ratner E., Leng S., et al. ASNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008, 68:8535-8540.
6. Cozzolino A.M., Pedace L., Castori M., et al. Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening. Fam Cancer 2012, 11:201-208.
7. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005, 41:2040-2059.
8. Ward K.A., Lazovich D., Hordinsky M.K. Germline melanoma susceptibility and prognostic genes: a review of the literature. JAm Acad Dermatol 2012, 67:1055-1067.
9. Yamazaki H., Chijiwa T., Inoue Y., et al. Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med 2012, 3:793-796.
10. Molnar V., Tamasi V., Bakos B., et al. Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas. Semin Cancer Biol 2008, 18:111-122.
11. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007, 12:414-418.
12. Sun F., Fu H., Liu Q., et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008, 582:1564-1568.
13. He L., He X., Lim L.P., et al. AmicroRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
14. Pedace L., De Simone P., Castori M., et al. Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma. Cancer Epidemiol 2011, 35:e116-e120.
15. Gentleman R.C., Carey V.J., Bates D.M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
16. Griffiths-Jones S., Saini H.K., van Dongen S., et al. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158.
17. Iuliano R., Vismara M.F., Dattilo V., et al. The role of microRNAs in cancer susceptibility. Biomed Res Int 2013, 2013:591931.
18. Saunders M.A., Liang H., Li W.H. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007, 104:3300-3305.